Synopsis

Raymond Halder, proprietor of a network of clinics, also orchestrates a sophisticated drug counterfeiting operation. When Gant Pharmaceuticals introduced a medication for primary vascular disease, the company initiated a recall following Halder’s saturation of the market with potentially lethal imitations. Gant intends to re-release the drug, but the IMF is tasked with preventing Halder from replicating the new formula. Federal agents, working with the IMF, apply pressure on Halder, yet he manag